01 1Glenmark Life Sciences Limited
02 1Hetero Labs Limited
03 1MSN Life Sciences Private Limited
04 1Siegfried Evionnaz SA
01 4Daclatasvir Dihydrochloride
01 3India
02 1Switzerland
NDC Package Code : 66039-941
Start Marketing Date : 2018-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0094
Start Marketing Date : 2015-07-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69766-063
Start Marketing Date : 2018-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17381-130
Start Marketing Date : 2015-07-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Daclatasvir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Daclatasvir, including repackagers and relabelers. The FDA regulates Daclatasvir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Daclatasvir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Daclatasvir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Daclatasvir supplier is an individual or a company that provides Daclatasvir active pharmaceutical ingredient (API) or Daclatasvir finished formulations upon request. The Daclatasvir suppliers may include Daclatasvir API manufacturers, exporters, distributors and traders.
click here to find a list of Daclatasvir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Daclatasvir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Daclatasvir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Daclatasvir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Daclatasvir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Daclatasvir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Daclatasvir suppliers with NDC on PharmaCompass.
We have 4 companies offering Daclatasvir
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
